お問い合わせフォーム
に入力の上、ご送信ください。詳細は折り返しメールでお伺いしますので簡単で結構です。
構造式をクリックして表示される詳細画面からでもお問い合わせいただけます。
| SCHEM No. | Structure | Compound Name | Price (JPY) | Purity | Stock(mg) |
|---|---|---|---|---|---|
| 04706 |  | N3-PEG13-COOMe | 73,500/2.5mg | >95% | 2.6 |
| 06024 |  | CONHS-PEG12-OCONHS | 93,000/7.5mg | >90% | 128.1 |
| 06457 |  | Cyclic(-PEG4-N-)-CO-PEG11-COOH | 71,500/0.1mg | >95% | 13.3 |
| 04666 |  | Bisphenol-A decacarbonate | 68,800/0.1mg | >95% | 3.2 |
| 02768 |  | COOtBu-PEG11-COOH | 66,500/25mg | >95% | 0 |
| 04665 |  | Bisphenol-A nonacarbonate | 68,800/0.1mg | >95% | 4.8 |
| 06023 |  | CONHS-PEG9-OCONHS | 93,000/7.5mg | >90% | 0 |
| 04664 |  | Bisphenol-A octacarbonate | 68,800/0.1mg | >95% | 6.8 |
| 06874 |  | COOtBu-PEG8-COOH | 68,900/7.5mg | >95% | 0 |
| 04663 |  | Bisphenol-A heptacarbonate | 68,800/0.1mg | >95% | 9.9 |
| 06873 |  | COOtBu-PEG7-COOH | 68,900/7.5mg | >95% | 0 |
| 05695 |  | Bis-DBCO of diaminoPEG7 | 64,000/0.7mg | >95% | 103.1 |
| 04662 |  | Bisphenol-A hexacarbonate | 68,800/0.1mg | >95% | 12.2 |
| 06870 |  | COOMe-PEG6-COOH | 63,800/100mg | >95% | 0 |
| 04819 |  | COOtBu-PEG6-COOH | 66,500/100mg | >95% | 8.7 |
| 04661 |  | Bisphenol-A pentacarbonate | 65,700/0.4mg | >95% | 12.7 |
| 06872 |  | COOtBu-PEG5-COOH | 66,500/100mg | >95% | 0 |
| 06022 |  | CONHS-PEG5-OCONHS | 97,000/5mg | >90% | 0 |
| 05588 |  | Bis-DBCO of diaminoPEG5 | 64,600/0.5mg | >95% | 28.3 |
| 04660 |  | Bisphenol-A tetracarbonate | 63,400/0.1mg | >95% | 10.4 |
| 02773 |  | COOMe-PEG5-COOH | 66,500/100mg | >95% | 423.0 |
| 06012 |  | CONHS-PEG4-OCONHS | 100,500/25mg | >90% | 180.6 |
| 04659 |  | Bisphenol-A tricarbonate | 68,800/0.2mg | >95% | 17.1 |
| 04313 |  | Piv-PEG4-OPiv | 70,800/750mg | >95% | 0 |
| 02216 |  | COOtBu-PEG4-COOH | inquire | >95% | 0 |
| 06871 |  | COOtBu-PEG3-COOH | inquire | >95% | 0 |
| 04658 |  | bis-Bisphenol-A dicarbonate | 65,700/0.4mg | >95% | 7.4 |
| 04071 |  | Me-PEG3-OCOCBrMe2 | 66,100/50mg | >95% | 111.8 |
| 03603 |  | Trt-PEG3-(OCO-PEG3)2-OTrt | 70,800/2.5mg | >95% | 0.4 |
| 03602 |  | Trt-PEG3-(OCO-PEG3)3-OTrt | 70,800/2.5mg | >95% | 2.9 |
| 03597 |  | Trt-PEG3-OCO-PEG3-COO-PEG3-OTrt | 64,000/5mg | >95% | 130.8 |
| 03549 |  | Cyclic(-PEG3-OCO-)4 | 66,700/0.7mg | >80% | 135.6 |
| 03548 |  | Cyclic(-PEG3-OCO-)3 | 71,500/5mg | >80% | 37.1 |
| 03547 |  | Cyclic(-PEG3-OCO-)2 | 71,500/5mg | >80% | 67.2 |
| 03546 |  | Cyclic(-PEG3-OCO-) | 68,400/0.4mg | >80% | 7.6 |
| 03512 |  | Trt-PEG3-OCO-PEG3-OTrt | 70,800/2.5mg | >95% | 75.3 |
| 02426 |  | OH-PEG3-OCO-PEG3-OH | 68,900/250mg | >95% | 2,000.0 |
| 01931 |  | Trt-PEG3-OCOSu | 64,900/75mg | >95% | 1,400.0 |
| 01930 |  | p-NPOC-PEG3-Methacrylate | 68,800/5mg | >90% | 1,000.0 |
| 01196 |  | Trt-PEG3-PNPOC | 70,800/2.5mg | >95% | 2,980.0 |
| 04657 |  | Bisphenol-A monocarbonate | 64,000/0.7mg | >95% | 18.6 |
| 03637 |  | Trt-BisphenolA-OCO-BisphanolA | 68,800/0.1mg | >95% | 0.1 |
| 06027 |  | CONHS-PEG2K-OCONHS | 97,000/5mg | <80% | 0 |
| 06026 |  | CONHS-PEG1.4K-OCONHS | 94,400/5mg | <80% | 0 |
| 06025 |  | CONHS-PEG1K-OCONHS | 96,000/7.5mg | <80% | 30.8 |
| 08734 |  | [(Z)-1-methylsulfonylethylideneamino] N-methylcarbamate | 50,000/1mg | >95% | 0.7 |
| 07517 |  | Dichloroprop methyl ester D3 | 66,300/2.5mg | >95% | 0 |
| 07516 |  | 2,4-DB methyl ester D3 | 66,300/2.5mg | >95% | 0 |
| 07508 |  | Mecoprop methylester | inquire | >95% | 10.0 |
| 06896 |  | 2,4,5-Triphenol glucuronide Methylester triacetate | 68,800/5mg | >90% | 42.0 |
| 06852 |  | 2,4-DB methyl ester | inquire | >95% | 0 |
| 06851 |  | Dichloroprop methyl ester | inquire | >95% | 138.1 |
| 06849 |  | 2,4-PA-methylester-d5 | 65,000/5mg | >95% | 0 |
| 06847 |  | 2,4-PA-methylester | 65,000/100mg | >95% | 106.4 |
| 06818 |  | 5-acetylpyrrolidin-2-one | 68,800/5mg | >95% | 111.1 |
| 06814 |  | 1,5-diacetylpyrrolidin-2-one | 64,900/7.5mg | >95% | 28,414.0 |
| 06633 |  | Phenthoate oxon | 68,800/5mg | >95% | 140.9 |
| 06607 |  | 2-[[(4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid | 66,300/5mg | >95% | 0.2 |
| 06108 |  | Mono-6-(NHS-C4-amide)-beta-cyclodextrin | 72,300/2.5mg | >80% | 18.0 |
| 06107 |  | Mono-6-(NHS-C4-amide)-alpha-cyclodextrin | 72,300/2.5mg | >80% | 14.0 |
| 06102 |  | Mono-6-(COOH-C4-NH)-beta-cyclodextrin | 68,800/5mg | >80% | 92.1 |
| 06101 |  | Mono-6-(COOH-C4-NH)-alpha-cyclodextrin | 68,800/5mg | >80% | 102.7 |
| 05979 |  | 5-ethoxy-5-oxohexyl triphenyl Phosphonium bromide | 63,400/100mg | >90% | 2,056.4 |
| 05939 |  | 5-cyanovaleramide | 64,900/75mg | >90% | 230.0 |
| 05915 |  | (E)-4-[2-[(5-bromoquinoxalin-6-yl)amino]-4,5-dihydroimidazol-1-yl]-4-oxo-but-2-enoic acid | 68,800/0.1mg | >95% | 26.0 |
| 05914 |  | N,N'-bis(2,5-dimethylpyrrol-1-yl)oxamide | inquire | >95% | 536.2 |
| 05873 |  | N-[2-(2,5-dioxopyrrolidin-1-yl)-3-isobutoxy-propyl]-N-phenyl-benzamide | 68,800/0.2mg | >95% | 0.2 |
| 05872 |  | N-(2-hydroxy-3-isobutoxy-propyl)-N-phenyl-benzamide | 72,300/2.5mg | >95% | 126.1 |
| 05863 |  | MOiDP | 65,700/0.4mg | >95% | 0 |
| 05856 |  | 2-((3-(benzyloxy)-3-oxopropoxy)carbonyl)benzoic-3,4,5,6-d4 acid | 68,800/0.1mg | >95% | 86.0 |
| 05854 |  | 2-((3-(benzyloxy)-3-oxopropoxy)carbonyl)benzoic acid | 64,000/0.7mg | >95% | 92.0 |
| 05846 |  | Doxycycline N-monodesmethyl | 64,000/0.7mg | >95% | 38.3 |
| 05835 |  | 2,4-Dichlorophenol glucuronide Methylester triacetate | 30,000/5mg | >90% | 35.3 |
| 05803 |  | N-demethyl-N-propargyl oxytetracycline | 76,000/0.1mg | >95% | 1.0 |
| 05798 |  | ethyl 4-(N-methylanilino)butanoate | 70,900/500mg | >95% | 4,398.8 |
| 05788 |  | isobutyl 2,4-dichlorophenoxycarbonate | 64,900/75mg | >95% | 2,240.0 |
| 05777 |  | Milbemectin A4 | 64,900/7.5mg | >95% | 114.7 |
| 05775 |  | 3,5-Di-tert-butyl-4-hydroxyphenylpropionicAcid monoethoxylate | 64,000/5mg | >95% | 385.0 |
| 05768 |  | Cyclosporin AM-1 | 76,000/0.1mg | >95% | 49.5 |
| 05765 |  | benzyl 2-(N-methylanilino)acetate | 72,300/25mg | >95% | 1,940.0 |
| 05677 |  | Benzyl alpha,beta-D-glucuronate | 68,100/750mg | >90% | 1,728.0 |
| 05673 |  | Allyl 2,3,4-tri-O-acetyl-alpha-D-glucopyranosyluronate bromide | 68,800/5mg | >90% | 350.0 |
| 05672 |  | 1,2,3,4-Tetra-O-acetyl-beta-D-glucuronic acid allyl ester | 63,400/5mg | >90% | 60.0 |
| 05670 |  | 2-(1-adamantyl-N-2,6-dimethylphenyl)-acetamide | 64,000/0.7mg | >95% | 84.7 |
| 05621 |  | Acetobromo-alpha-D-glucuronic acid methyl ester | 12,000/1,000mg | >90% | 13,081.4 |
| 05612 |  | N-(2,6-dimethylphenyl)-N-(hydroxyacetyl)alanine methyl ester | 63,400/0.2mg | >90% | 149.0 |
| 05609 |  | N-(2,6-Dimethylphenyl)-N-(methoxyacetyl)-DL-alanine methyl ester | inquire | >90% | 573.0 |
| 05603 |  | methyl 2-(N-2,6-dimethylphenyl)aminopropionate | 68,800/5mg | >95% | 10.0 |
| 05568 |  | Acetamide, N-(3,6,8-tribromo-1-pyrenyl)- | 64,900/7.5mg | >95% | 277.6 |
| 05567 |  | 1-acetylaminopyrene | 64,600/0.5mg | >95% | 55.0 |
| 05518 |  | spiromesifen | 63,400/50mg | >95% | 325,700.0 |
| 05506 |  | 2-propenoic acid, 2-methyl-3-nitro-, methy ester | 64,600/0.5mg | >95% | 313.2 |
| 05425 |  | Pilsicainide.HCl D6 | 76,000/0.1mg | >95% | 64.0 |
| 05391 |  | (2,3-dihydroxy-1-methoxycarbonyl-propyl) 2,2-dimethylpropanoate | 64,000/5mg | >90% | 252.6 |
| 05390 |  | [1-(2,2-dimethyl-1,3-dioxolan-4-yl)-2-methoxy-2-oxo-ethyl] 2,2-dimethylpropanoate | 69,300/250mg | >95% | 2,031.0 |
| 05374 |  | 2-[[(1S,2R)-1-(fluoromethyl)-2-hydroxy-2-(4-methylsulfonylphenyl)ethyl]amino]-2-oxo-acetic acid | 64,000/5mg | >95% | 73.3 |
| 05372 |  | N-[(1S,2R)-1-(fluoromethyl)-2-hydroxy-2-(4-methylsulfonylphenyl)ethyl]-2-hydroxy-acetamide | 70,000/25mg | >95% | 82.4 |
| 05231 |  | Propyl 2-[3-oxo-2-(2-oxoethyl)cyclopentyl]acetate | 63,400/50mg | >95% | 2,144.4 |
| 05227 |  | propyl 2-[3-oxo-2-[(Z)-pent-2-enyl]cyclopentyl]acetate | 69,300/250mg | >95% | 18,602.0 |
| 05175 |  | (3,4-dimethoxy-4-oxo-butyl)-trimethyl-ammonium | 64,000/5mg | >90% | 32.5 |
| 05052 |  | Carbaryl-D7 | 55,000/20mg | >95% | 0 |
| 05047 |  | Isoprothiolane-D4 | 55,000/20mg | >95% | 0 |
| 05033 |  | Ampicillin-D5 | 77,000/10mg | >95% | 0 |
| 05030 |  | Mono-n-butyl phthalate | 60,000/20mg | >95% | 0 |
| 04813 |  | Mono-6-(COOH-C3-CO-NH)-beta-cyclodextrin | 64,000/0.7mg | >95% | 17.8 |
| 04282 |  | Mono TSE succinic acid | 63,400/50mg | >95% | 1,400.0 |
| 04234 |  | 2-imino-1,5-dimethyl-imidazolidin-4-one | 64,000/5mg | >95% | 554.0 |
| 04151 |  | Heat Shock Protein Inhibitor II | 68,100/0.2mg | >95% | 7.3 |
| 04140 |  | ethyl 7,7-dicyanoheptanoate | 82,300/2.5mg | >95% | 0.1 |
| 04049 |  | (3-azido-2-hydroxy-1-methoxycarbonyl-propyl) 2,2-dimethylpropanoate | 64,000/5mg | >90% | 37.3 |
| 03616 |  | Naphthalene-2-carboxylic acid ethyl ester | inquire | >95% | 13,450.0 |
| 03606 |  | ethyl 2-(5-ethoxycarbonyl)pentyl-2-methylacetoacetate | 70,800/2.5mg | >95% | 7.4 |
| 03541 |  | Mono-6-O-tBu-acetate-beta-cyclodextrine mixture of isomers | 68,900/2.5mg | >95% | 439.8 |
| 03505 |  | Glycerol(Trt)(Palmitoyl)[Palmitoyl} | 63,400/50mg | >95% | 54.6 |
| 03486 |  | Glycerol(Trt)(DMT)[linolate] | 64,000/5mg | >95% | 8.8 |
| 03485 |  | Glycerol(Trt)(Pal)[OH] | 63,400/50mg | >95% | 93.9 |
| 02732 |  | [3-azido-5-(9H-fluoren-9-ylmethoxycarbonylamino)phenyl]methyl (4-nitrophenyl) carbonate | 65,700/0.4mg | >95% | 0 |
| 02705 |  | L-Glu(Me)-OMe.HCl | inquire | >95% | 730.0 |
| 02646 |  | 5-Hydroxypentanoic Acid Methyl Ester | 63,400/50mg | >95% | 3,000.0 |
| 02622 |  | N-benzyl trichloroacetamide | 72,300/2.5mg | >95% | 0 |
| 02337 |  | (4-nitrophenyl) vinyl carbonate | 80,900/75mg | >95% | 137.0 |
| 01964 |  | 1-(2-amino-2-oxo-ethyl)pyridin-1-ium-3-carboxamide | 69,300/250mg | >95% | 2,050.0 |
| 01856 |  | Methyl 2-iodoacetate | 66,300/25mg | >95% | 1,000.0 |
| 01853 |  | N-Piperidin-2-ylmethyl-2,5-bis-(2,2,2-trifluoro-ethoxy)-benzamide | 64,000/5mg | >95% | 246.0 |
| 01708 |  | [4-(3,4-Difluorobenzoyl)oxyphenyl] 3,4-difluorobenzoate | 64,600/0.5mg | >80% | 145.0 |
| 01446 |  | Methylazoxymethanol acetate | 45,000/20mg | >95% | 6,800.0 |
| 01401 |  | Octanediamide | 68,400/0.4mg | >95% | 1.0 |
| 01358 |  | 3-(2,2,2-trifluoro-acetyl)-dihydro-furan-2-one | 67,900/750mg | >95% | 7,890.1 |
| 00742 |  | 8-Ethoxy-[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid ethyl ester | 72,300/500mg | >95% | 8,200.1 |
| 00684 |  | 3-(3,4-Dihydroxy-phenyl)-acrylic acid ethyl ester | inquire | >95% | 10.0 |
| 00683 |  | 3-(3,4-Bis-benzyloxy-phenyl)-acrylic acid ethyl ester | 64,600/0.5mg | >95% | 20.0 |
| 00651 |  | 4-Amino-N-(5-methyl-isoxazol-3-yl)-benzenesulfonamide-d4 | 68,000/10mg | >95% | 817.0 |
| 00413 |  | 1H-Imidazolium, 1,2-dimethyl-3-[(2,2,2-trichloroethoxy)sulfonyl]-, 1,1,1-trifluoromethanesulfonate | 70,000/25mg | >95% | 466.0 |
| 00384 |  | 8-Chloro-[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid ethyl ester | 63,400/50mg | >95% | 1,960.0 |
| 00352 |  | 2,2,2-Trichloroethyl chlorosulfate | inquire | <80% | 2,521.7 |
| 00279 |  | methyl 3-bis(3-methoxy-3-oxo-propyl)phosphanylpropanoate | 72,300/25mg | >90% | 181.4 |
| 00180 |  | N-(2,4-Dichloro-phenyl)-malonamic acid ethyl ester | 70,000/25mg | >90% | 3,320.1 |
| 00177 |  | tribromoacetamide | 64,600/0.5mg | >95% | 0 |
